Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: Increased binding of cyclin a negatively regulates E2F transactivation activity

Cancer Research

Volumn 57, Issue 13, 1997, Pages 2668-2675

  Turley, Jennifer M ^a   Ruscetti, Francis W ^a   Kim, Seong Jin ^b   Fu, Tao ^a   Gou, F Victoria ^a   Birchenall Roberts, Maria C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL SUCCINATE; CYCLIN A; ESTROGEN RECEPTOR;

ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DELETION MUTANT; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TRANSACTIVATION; TRANSCRIPTION REGULATION; VITAMIN METABOLISM;

BLOTTING, WESTERN; BREAST NEOPLASMS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL DIVISION; CYCLINS; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; FEMALE; HUMANS; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; VITAMIN E;

EID: 0030793191     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Niki, E., Yamamoto, Y., Komour, M., and Miyana, Y. Inhibition of oxidation of biomembranes by tocopherol. In: A. T. Diplock, L. J. Machlin, L. Packer, and W. A. Pryor (eds.), Vitamin E: Biochemistry and Health Implications, pp. 23-25. New York: Annals of the New York Academy of Science, 1989.
2. Prasad, K. N., and Edwards-Prasad, J. Vitamin E and cancer prevention: recent advances and future potentials. J. Am. Coll. Nutr., 11: 487-500, 1992.
3. Turley, J. M., Sanders, B. G., and Kline, K. RRR-α-tocopheryl succinate modulation of human promyelocytic leukemia (HL-60) cell proliferation and differentiation. Nutr. Cancer, 18: 201-213, 1992.
4. Turley, J. M., Funakoshi, S., Ruscetti, F. W., Kasper, J., Murphy, W. J., Longo, D. L., and Birchenall-Roberts, M. C. Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: role for transforming growth factor β. Cell Growth & Differ., 6: 655-663, 1995.
5. Charpentier, A., Groves, S., Simmons-Menchaca, M., Turley, J., Zhao, B., Sanders, B. G., and Kline, K. RRR-α-tocopheryl succinate inhibits proliferation and enhances secretion of transforming growth factor-β (TGF-β) by human breast cancer cells. Nutr. Cancer, 19: 225-239, 1993.
6. Slack, R., and Proulx, P. Studies on the effects of vitamin E on neuroblastoma NIE 115 cells. Nutr. Cancer, 12: 75-82, 1989.
7. Prasad, K. N., and Edwards-Prasad, J. Effects of tocopherol (vitamin E) acid succinate on morphological alterations and growth inhibition in melanoma cells in culture. Cancer Res., 42: 550-555, 1982.
8. Fariss, M. W., Fortuna, M. B., Everett, C. K., Smith, J. D., Trent, D. F., and Djuric, Z. The selective antiproliferative effects of α-tocopheryl hemisuccinate and cholesteryl hemisuccinate on murine leukemia cells results from the action of the intact compounds. Cancer Res., 54: 3346-3351, 1994.
9. Prasad, K. N., Cohrs, R. J., and Sharma, O. K, Decreased expression of c-myc and H-ras oncogenes in vitamin E succinate induced morphologically differentiated murine B-16 melanoma cells in culture. Biochem, Cell Biol., 68: 1250-1255, 1990.
10. Cohrs, R. J., Torelli, S., Prasad, K. N., Edwards-Prasad, J., and Sharma, O. K. Effect of vitamin E succinate and a cAMP stimulating agent on the expression of c-myc, N-myc and H-ras in murine neuroblastoma cells. Int. J. Devl. Neurosci 9: 187-194, 1991.
11. Kelloff, G. J., Crowell, J. A., Boone, C. W., Steele, V. E., Lubet, R. A., Greenwald, P., Alberts, D. S., Covey, J. M., Doody, L. A., Knapp, G. G., Nayfield, S., Parkinson, D. R., Prasad, V. K., Prorok, P. C., Sausville, E. A., and Sigman, C. C. Clinical development plans for cancer chemopreventive agents. J. Cell. Biochem. Suppl., 20: 282-294, 1994.
12. Sahu, S. N., Edwards-Prasad, J., and Prasad, K. N. Effect of α-tocopheryl succinate on adenylate cyclase activity in murine neuroblastoma cells in culture. J. Am, Coll. Nutr., 7: 285-293, 1988.
13. Torelli, S., Masoudi, F., and Prasad, K. N. Effect of tocopheryl succinate activity on cyclic AMP-dependent protein kinase activity in B16 melanoma cells in culture. Cancer Lett., 39: 129-136, 1988.
14. Boscoboinik, D., Szewezyk, A., Hensey, C., and Azzi, A. Inhibition of cell proliferation by α-tocopherol: role of protein kinase C. J. Biol. Chem., 266: 6188-6194, 1991.
15. Boscoboinik, D., Szewezyk, A., and Azzi, A. α-Tocopherol (vitamin E) regulates vascular smooth muscle cell proliferation and protein kinase C activity. Arch. Biochem. Biophys., 286: 264-269, 1991.
16. Chatelain, E., Boscoboinik, D. O., Bartoli, G. M., Kagan, V. E., Gey, F. K., Packer, L., and Azzi, A. Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienols. Biochim. Biophys. Acta, 1176: 83-89, 1993.
17. Ishida, S., Shudo, K., Takada, S., and Koike, K. Transcription from the P2 promoter of human protooncogene myc is suppressed by retinoic acid through an interaction between the E2F element and its binding proteins. Cell Growth & Differ. 5: 287-294, 1994.
18. Schwarz, J. K., Bassing, C. H., Kovesdi, I., Datto, M. B., Blazing, M., George, S., Wang, X., and Nevins, J. R. Expression of the E2F1 transcription factor overcomes type β transforming growth factor-mediated growth suppression. Proc. Natl. Acad. Sci. USA, 92: 483-487, 1995.
19. Sardet, C., Vidal, M., Corbrinik, D., Geng, Y., Onufryk, C., Chen, A., and Weinberg, R. A. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc. Natl. Acad. Sci. USA, 92: 2403-2407, 1995.
20. Weinberg, R. A. E2F and cell proliferation: a world turned upside down. Cell, 85: 457-459, 1996.
21. Morishita, R., Gibbons, G. H., Horiuchi, M., Ellison, K. E., Nakajima, M., Zhang, L., Kaneda, Y., Ogihara, T., and Dzau, V. J. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Proc. Natl. Acad. Sci. USA, 92: 5855-5859, 1995.
22. Field, S. J., Tsai, F., Kuo, F., Zubiaga, A. M., Kaelin, W, G., Jr., Livingston, D. M., Orkin, S. H., and Greenberg, M. E. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell, 85: 549-561, 1996.
23. Yamasaki, L., Jacks, T., Bronson, R., Goillot, E., Harlow, E., and Dyson, N. J. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell, 85: 537-548, 1996.
24. Weintraub, S. J., Prater, C. A., and Dean, D. C. Retinoblastoma protein switches the E2F site from positive to negative element. Nature (Lond.), 358: 259-261, 1992.
25. Sherr, C. J. The ins and outs of RB: coupling gene expression to the cell cycle clock. Trends Biochem. Sci., 4: 15-18, 1994.
26. Fagan, R., Flint, K. J., and Jones, N. Phosphorylation of E2F-1 modulates its interaction with the retinoblastoma gene product and the adenoviral E4 19 kDa protein. Cell, 78: 799-811, 1994.
27. Chittenden, T., Livingston, D. M., and DeCaprio, J. A. Cell cycle analysis of E2F in primary human T cells reveals novel E2F complexes and biochemically distinct forms of tree E2F. Mol. Cell. Biol., 13: 3975-3983, 1993.
28. Devoto, S. H., Mudryj, M., Pines, J., Hunter, T., and Nevins, J. R. A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex. Cell, 68: 167-176, 1992.
29. Shirodkar, S., Ewen, M., DeCaprio, J. A., Morgan, J., Livingston, D. M., and Chittenden, T. The transcription factor E2F interacts with the retinoblastoma product and a p 107-cyclin A complex in a cell cycle-regulated manner. Cell, 68: 157-166, 1992.
30. Kalo, J., Matsushime, H., Hiebert, S. W., Ewen, M. E., and Sherr, C. J. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev., 7: 331-342, 1993.
31. Krek, W., Ewen, M. E., Shirodkar, S., Arany, Z., Kaelin, W. G. J., and Livingston, D. M. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell, 78: 161-172, 1994.
32. Mudryj, M., Devoto, S. H., Pines, J., and Nevins, J. R. Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A. Cell, 65: 1243-1253, 1991.
33. Hinds, P. W., Mittnacht, S., Dulic, V., Arnold, A., Reed, S. I., and Weinberg, R. A. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell, 70: 993-1006, 1992.
34. cdk-2 to the cellular transcription factor DRTF1. J. Cell Sci. Suppl., 16: 77-85, 1992.
35. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
36. Stein, G. S., Stein, J. L., van Wijnen, A. J., and Lian, J. B. Histone gene transcription: a model for responsiveness to an integrated series of regulatory signals mediating cell cycle control and proliferation/differentiation interrelationships. J. Cell. Biochem., 54: 393-404, 1994.
37. Zhang, H., Hannon, G. J., and Beach, D. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev., 8: 1750-1758, 1994.
38. Oswald, F., Lovec, H., Moray, T., and Lipp, M. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions. Oncogene, 9: 2029-2036, 1994.
39. Heichman, K. A., and Roberts, J. M. Rules to replicate by. Cell, 79: 557-562, 1994.
40. Carbonaro-Hall, D., Williams, R., Wu, L., Warburton, D., Zeichner-David, M., MacDougall, M., Tolo, V., and Hall, F. G1 expression and multistage dynamics of cyclin A in human osteosarcoma cells. Oncogene, 8: 1649-1659, 1993.
41. Kip 1. Mol. Cell. Biol., 15: 4347-4352, 1995.
42. cip 1 cyclin-dependent kinase inhibitor. Oncogene, 10: 2281-2287, 1995.
43. Dimri, G. P., Nakanishi, M., Desprez, P., Smith, J. R., and Campisi, J. Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein. Mol. Cell. Biol., 16: 2987-2997, 1996.
44. Weistat-Saslow, D., Merino, M. J., Manrow, R. E., Lawrence, J. A., Bluth, R. F., Wittenbel, K. D., Simpson, J. F., Page, D. L., and Steeg, P. S. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nature Med., 1: 1257-1260, 1995.
45. Keyomarsi, K., and Pardee, A. B. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc. Natl. Acad. Sci. USA, 90: 1112-1116, 1993.
46. Haldar, S., Negrini, M., Monne, M., Sabbioni, S., and Croce, C. M. Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res., 54: 2095-2097, 1994.
47. cdc2 expression and normal p53 suppresses cyclin A expression. Exp. Cell Res., 210: 94-101, 1994.
48. Thalmeier, K., Synovzik, H., Menrtz, R., Winnacker, E. L., and Lipp, M. Nuclear factor E2F mediates basic transcription and trans-activalion by E1a of the human MYC promoter. Genes Dev., 3: 527-536, 1989.
49. Nevins, J. R. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science (Washington DC), 258: 424-429, 1992.
50. Hiebert, S. W., Lipp, M., and Nevins, J. R. E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor. Proc. Natl. Acad. Sci. USA, 86: 3594-3598, 1989.
51. Miller, T. L., Huzel, N. J., Davie, J. R., and Murphy, L. C. c-myc gene chromatin of estrogen receptor positive and negative breast cancer cells. Mol. Cell. Endocrinol., 91: 83-89, 1993.
52. Watson, P. H., Pon, R. T., and Shiu, R. P. C. Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer. Cancer Res., 51: 3996-4000, 1991.
53. Ray, R. B., Steele, R., Seftor, E., and Hendrix, M. Human breast carcinoma cells transfected with the gene encoding a c-myc promoter-binding protein (MBP-1) inhibits tumors in nude mice. Cancer Res., 55: 3747-3751, 1995.
54. Lasfargues, E. Y., and Ozzello, L. Cultivation of human breast carcinomas. J. Natl. Cancer Inst., 21: 1131-1147, 1958.
55. Hoffeld, J. T. Agents which block membrane lipid peroxidation enhance mouse spleen cell immune activities in vitro: relationship to the enhancing activity of 2-mercaptoethanol. Eur. J. Immunol., 11: 371-376, 1981.
56. Schreck, R., Rieber, P., and Baeuerle, R. A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kB transcription factor and HIV-1. EMBO J., 10: 2247-2258, 1991.
57. Kaelin, W. G., Krek, W., Seller, W. R., DeCaprio, J. A., Ajchenbaum, F., Fuchs, C. S., Chittenden, T., Li, Y., Farnham, P. J., Blanar, M. A., Livingston, D. M., and Flemington, E. K. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell, 70: 351-364, 1992.
58. Siebenlist, U., Henninghausen, L., Battey, J., and Leder, P. Chromatin structure and protein binding in the putative regulatory region of the c-myc gene in Burkitt lymphoma. Cell, 37: 381-391, 1984.
59. Angel, P., Hattori, K., Smeal, T., and Karin, M. The jun proto-oncogene is positively autoregulated by its product, jun/AP-1. Cell, 55: 875-885, 1988.
60. Kim, S. J., Onwuta, U. S., Lee, Y. I., Li, R., Botchan, M. R., and Robbins, P. D. The retinoblastoma gene product regulates Sp1-mediated transcription. Mol. Cell. Biol., 12: 2455-2463, 1992.
61. Birchenall-Roberts, M. C., Ruscetti, F. W., Kasper, J., Lee, H., Friedman, R., Geiser, A., Sporn, M. B., Roberts, A. B., and Kim, S. J. Transcriptional regulation of the transforming growth factor B1 promoter by v-src gene products is mediated through the AP-1 complex. Mol. Cell. Biol., 10: 4978-4983, 1990.
62. Gorman, C. M., Moffat, L. F., and Howard, B. H. Recombinant genomes which express chloramphenicol acetyl-transferase. Mol. Cell. Biol., 2: 1044-1051, 1982.
63. Nakajima-Iijima, S., Hamada, H., Reddy, P., and Kakunaga, T. Molecular structure of the human cytoplasmic β-actin gene: interspecies homology of sequences in the introns. Proc. Natl. Acad. Sci. USA, 82: 6133-6137, 1985.
64. Gazin, C., Dupont de Dinechin, S., Hampe, A., Masson, J. M., Martin, P., Stehelin, D., and Galibert, F. Nucleotide sequence of the human c-myc locus: provocative open reading frame within the first exon. EMBO J., 3: 383-387, 1984.
65. Kitagawa, M., Higashi, H., Suzuki-Takahashi, I., Segawa, K., Hanks, S. K., Nishimura, S., and Okuyama, A. Phosphorylation of E2F-1 by cyclin A-cdk2. Oncogene, 10: 229-236, 1995.
66. Xu, M., Sheppard, K., Peng, C., Yee, A. S., and Piwnica-Worms, H. Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. Mol. Cell. Biol., 14: 8420-8431, 1994.
67. Dynlacht, B. D., Flores, O., Lees, J. A., and Harlow, E. Differential regulation of E2F trans-activauon by cyclin/cdk2 complexes. Genes Dev., 8: 1772-1786, 1994.
68. Kerr, L. D., Miller, D. B., and Matrisian, L. M. TGF-β1 inhibition of transin/ stromelysin gene expression is mediated through a Fos binding sequence. Cell, 61: 267-278, 1990.
69. Horton, L. E., Qian, Y., and Templeton, D. J. G1 cyclins control the retinoblastoma gene product growth regulation activity via upstream mechanisms. Cell Growth & Differ., 6: 395-407, 1995.
70. Castro, A., Jaumot, M., Verges, M., Agell, N., and Bachs, O. Microsomal localization of cyclin A and cdk2 in proliferating rat liver cells. Biochem. Biophys. Res. Commun., 201: 1072-1078, 1994.
71. Bendich, A., and Machlin, L. J. Safety of oral intake of vitamin E. Am. J. Clin. Nutr., 48: 612-619, 1988.
72. Knekt, P., Aromaa, A., Maatela, J., Aaran, R, Nikkari, T., Hakama, M., Hakulinen, T., Peto, R., and Teppo, L. Vitamin E and cancer prevention. Am. J. Clin. Nutr., 53: 283S-286S, 1991.
73. Floyd, R. A. Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J., 4: 2587-2597, 1990.